Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05483374Recruiting

The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers

Role: collaborator

NCT05947903Not Yet Recruiting

Validation of the European Oncology Quality of Life Toolkit

Role: collaborator

NCT06339541Recruiting

The ACC Preclinical Research Platform for Precision Oncology

Role: collaborator

NCT05630664Unknown

Liquid Biopsy in High-grade Gliomas and Meningiomas

Role: collaborator

All 4 trials loaded